KBC Group
AMRX icon

KBC Group’s Amneal Pharmaceuticals AMRX Stock Holding History

KBC Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$129K Hold
6,417
– – ﹤0.01% 1241
2026
Q2 		$111K Hold
6,417
– – ﹤0.01% 1354
2026
Q1 		$80K Buy
+6,417
New +$86.2K ﹤0.01% 1453
2019
Q4 		– Sell
-55,579
Closed -$161K – 1493
2019
Q3 		$161K Buy
+55,579
New +$194K ﹤0.01% 1283

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Signature Wealth Management Partners
Signature Wealth Management Partners Montvale, New Jersey $234M AUM 23.06% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Campbell Newman Asset Management
Campbell Newman Asset Management Milwaukee, Wisconsin $1.33B AUM 26.63% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

KBC Group's AMRX Position: Q3 2026 in Review

KBC Group held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 6,417 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

KBC Group first reported a position in AMRX in Q3 2019 and has held it in 4 quarters since. The position peaked at $161K in Q3 2019. 68 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • KBC Group held 6,417 shares of Amneal Pharmaceuticals worth $129K as of Q3 2026.
  • KBC Group left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1241 holding.
  • KBC Group first reported a position in Amneal Pharmaceuticals in Q3 2019 and has held it in 4 quarters since.
  • KBC Group's Amneal Pharmaceuticals position peaked at $161K in Q3 2019.
  • 68 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.